Luca Ricci-Basso

Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2.

Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2.

Journal: Molecular therapy. Methods & clinical development
Published: September 16, 2025

Molecular and phenotypic blueprint of human hematopoiesis links proliferation stress to stem cell aging.

Molecular and phenotypic blueprint of human hematopoiesis links proliferation stress to stem cell aging.

Journal: The Journal of experimental medicine
Published: September 02, 2025

Evolution of hematopoietic stem cell potential from preterm to term neonates.

Evolution of hematopoietic stem cell potential from preterm to term neonates.

Journal: HemaSphere
Published: August 05, 2025

Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Journal: Nature medicine
Published: July 08, 2024

Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning.

Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning.

Journal: Frontiers in endocrinology
Published: June 17, 2024

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Journal: The Journal of allergy and clinical immunology
Published: May 06, 2024

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential.

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential.

Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 24, 2024

In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking.

In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking.

Journal: Nature
Published: February 08, 2024

Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency.

Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency.

Journal: Science translational medicine
Published: February 07, 2024

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis.

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis.

Journal: Blood
Published: September 22, 2023

Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders.

Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders.

Journal: Science translational medicine
Published: May 31, 2023

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 12, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026